Skip to content
Biodatica
Start free

Hackensack Meridian Health

Hackensack, New Jersey

OncologyPhase II
Compare Sign in to watch

What changed

Phase II trial registered: Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

3d agoTrial registeredJul 17, 2026Source filing (opens the source filing in a new tab)

Momentum

100no change

Momentum 100 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

1,843 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE2 registered

    Aug 30, 2026

    Acneiform Drug Eruption, Acneiform Eruptions · NOT_YET_RECRUITING · sponsor: University of California, San Francisco · Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathway

    ClinicalTrials.gov · NCT07629167 (opens the source filing in a new tab)

  2. Trial

    PHASE2 registered

    Jun 17, 2026

    Recurrent Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS · RECRUITING · sponsor: Sabine Mueller, MD, PhD · Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

    ClinicalTrials.gov · NCT07447076 (opens the source filing in a new tab)

  3. Trial

    PHASE2 registered

    May 5, 2026

    Posterior Fossa Ependymal Tumor · RECRUITING · sponsor: University of California, San Francisco · Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma

    ClinicalTrials.gov · NCT07226453 (opens the source filing in a new tab)

  4. Trial

    PHASE2 registered

    Nov 7, 2025

    BRAF V600 Mutation, Low-grade Glioma, Low Grade Glioma of Brain, Recurrent Low Grade Glioma · RECRUITING · sponsor: University of California, San Francisco · Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

    ClinicalTrials.gov · NCT07110246 (opens the source filing in a new tab)

  5. Trial

    PHASE2 registered

    Mar 6, 2025

    Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Multilayered Rosettes, Nos · RECRUITING · sponsor: University of California, San Francisco · Embryonal Tumor With Multilayered Rosettes

    ClinicalTrials.gov · NCT06861244 (opens the source filing in a new tab)

  6. Trial

    Study registered

    Jul 12, 2020

    Embryonal Tumor With Multilayered Rosettes · RECRUITING · sponsor: Hackensack Meridian Health · ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes

    ClinicalTrials.gov · NCT04794686 (opens the source filing in a new tab)

  7. Trial

    PHASE1 registered

    Apr 3, 2019

    Glioblastoma, IDH1 Gene Mutation, IDH2 Gene Mutation, Low Grade Glioma, Malignant Glioma, Recurrent Glioblastoma, Recurrent WHO Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma, WHO Grade III Glioma · ACTIVE_NOT_RECRUITING · sponsor: University of California, San Francisco · BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

    ClinicalTrials.gov · NCT03749187 (opens the source filing in a new tab)

  8. Trial

    NA registered

    Nov 28, 2018

    Glioma, Glioma of Brain, Cancer, Pediatric Cancer, Pediatric Brain Tumor, Astrocytoma, Glioblastoma, Hemispheric · ACTIVE_NOT_RECRUITING · sponsor: University of California, San Francisco · Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma

    ClinicalTrials.gov · NCT03739372 (opens the source filing in a new tab)

  9. Trial

    PHASE1 registered

    Apr 6, 2017

    High Grade Glioma, Ependymoma · COMPLETED · sponsor: Hackensack Meridian Health · HUMC 1612: Optune NovoTTF-200A System

    ClinicalTrials.gov · NCT03128047 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources